Gemtuzumab ozogamicin and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Gemtuzumab ozogamicin and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: gemtuzumab
Brand name: Mylotarg
Synonyms: Gemtuzumab Ozogamicin
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Gemtuzumab ozogamicin-Insulin degludec
- Gemtuzumab ozogamicin-Insulin Degludec (U-100) Prefilled Pens
- Gemtuzumab ozogamicin-Insulin Degludec (U-100) Vials
- Gemtuzumab ozogamicin-Insulin Degludec (U-200) Prefilled Pens
- Gemtuzumab ozogamicin-Insulin degludec and liraglutide
- Gemtuzumab ozogamicin-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Gemzar
- Insulin aspart, recombinant Subcutaneous-Gen-Amoxicillin
- Insulin aspart, recombinant Subcutaneous-Gen-Amoxicillin Oral
- Insulin aspart, recombinant Subcutaneous-Gen-Budesonide Aq
- Insulin aspart, recombinant Subcutaneous-Gen-Minoxidol Topical
- Insulin aspart, recombinant Subcutaneous-Gen-Nitro